| 329 |
Excessive reactive oxygen species production leading to mortality (3) |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
350: Increase, Mortality
|
|
|
| 330 |
Excessive reactive oxygen species production leading to mortality (4) |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
350: Increase, Mortality
|
|
|
| 332 |
Reactive oxygen species leading to growth inhibition via protein oxidation and decreased cell proliferation |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
1521: Decrease, Growth
|
|
|
| 333 |
Reactive oxygen species leading to growth inhibition via protein oxidation and cell death |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
1521: Decrease, Growth
|
|
|
| 338 |
DNA methyltransferase inhibition leading to population decline (3) |
You Song |
BY-SA |
1619: Increase, DNA methyltransferase inhibition
|
2 AOs
|
|
|
| 331 |
Reactive oxygen species leading to growth inhibition via lipid peroxidation and cell death |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
1521: Decrease, Growth
|
|
|
| 324 |
Reactive oxygen species leading to growth inhibition via oxidative DNA damage and cell cycle disruption |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
1521: Decrease, Growth
|
|
|
| 335 |
AOP for urothelial carcinogenesis due to chemical cytotoxicity by mitochondrial impairment |
Nathalia Pereira Souza |
BY-SA |
177: Increase, Mitochondrial dysfunction
|
1763: Urothelial Tumor
|
|
|
| 302 |
Lung surfactant function inhibition leading to decreased lung function |
Jorid Birkelund Sørli |
BY-SA |
1672: Inhibition of lung surfactant function
|
1250: Decrease, Lung function
|
Under Development |
1.87 |
| 618 |
PPARgamma activation leads to a diminished vaccine response |
Léo SPORTES-MILOT |
BY-SA |
1028: Activation of specific nuclear receptors, PPAR-gamma activation
|
2397: Diminished vaccine response
|
|
|
| 578 |
AhR activation leading to cancer progression via immunosuppression |
Léo SPORTES-MILOT |
BY-SA |
18: Activation, AhR
|
1971: Increased, tumor growth
|
|
|
| 312 |
Acetylcholinesterase Inhibition leading to Acute Mortality via Impaired Coordination & Movement |
Kristie Sullivan |
BY-SA |
12: Acetylcholinesterase (AchE) Inhibition
|
2 AOs
|
|
|
| 152 |
Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity |
Kristie Sullivan |
BY-SA |
957: Binding, Transthyretin in serum
|
402: Cognitive function, decreased
|
Under Development |
1.41 |
| 575 |
Decreased testosterone synthesis leading to increased nipple retention (NR) in male (rodent) offspring |
Terje Svingen |
BY-SA |
None
|
1786: Nipple retention (NR), increased
|
|
|
| 576 |
5α-reductase inhibition leading to increased nipple retention (NR) in male (rodent) offspring |
Terje Svingen |
BY-SA |
1617: Inhibition, 5α-reductase
|
1786: Nipple retention (NR), increased
|
|
|
| 305 |
5α-reductase inhibition leading to short anogenital distance (AGD) in male (mammalian) offspring |
Terje Svingen |
BY-SA |
1617: Inhibition, 5α-reductase
|
1688: anogenital distance (AGD), decreased
|
Under Review |
1.90 |
| 306 |
Androgen receptor (AR) antagonism leading to short anogenital distance (AGD) in male (mammalian) offspring |
Terje Svingen |
BY-SA |
26: Antagonism, Androgen receptor
|
1688: anogenital distance (AGD), decreased
|
Under Review |
1.90 |
| 570 |
Decreased testosterone synthesis leading to hypospadias in male (mammalian) offspring |
Terje Svingen |
BY-SA |
None
|
2082: Hypospadias, increased
|
|
|
| 571 |
5α-reductase inhibition leading to hypospadias in male (mammalian) offspring |
Terje Svingen |
BY-SA |
1617: Inhibition, 5α-reductase
|
2082: Hypospadias, increased
|
|
|
| 400 |
Inhibition of CYP26B1 activity in fetal testis leading to reduced fertility |
Terje Svingen |
BY-SA |
1887: Inhibition of CYP26B1 activity
|
406: decreased, Fertility
|
|
|
| 477 |
Androgen receptor (AR) antagonism leading to hypospadias in male (mammalian) offspring |
Terje Svingen |
BY-SA |
26: Antagonism, Androgen receptor
|
2082: Hypospadias, increased
|
|
|
| 398 |
Decreased ALDH1A (RALDH) activity leading to decreased fertility via disrupted meiotic initiation of fetal oogonia |
Terje Svingen |
BY-SA |
1880: Decreased, ALDH1A (RALDH) enzyme activity
|
406: decreased, Fertility
|
Under Development |
1.97 |
| 344 |
Androgen receptor (AR) antagonism leading to nipple retention (NR) in male (mammalian) offspring |
Terje Svingen |
BY-SA |
26: Antagonism, Androgen receptor
|
1786: Nipple retention (NR), increased
|
Under Development |
1.108 |
| 345 |
Androgen receptor (AR) antagonism leading to decreased fertility in females |
Terje Svingen |
BY-SA |
26: Antagonism, Androgen receptor
|
2 AOs
|
Under Development |
1.109 |
| 307 |
Decreased testosterone synthesis leading to short anogenital distance (AGD) in male (mammalian) offspring |
Terje Svingen |
BY-SA |
None
|
1688: anogenital distance (AGD), decreased
|
Under Review |
1.90 |